Nystatin Oral Suspension Articles
Hybrigenics receives 1.4M-euro award from OSEO
15 September 2008
Merck Serono's Glucophage sachet gets nod from CHMP
15 September 2008
Japan stock market week to Sept 8, 2008
15 September 2008
Astellas looking to overtake Takeda's leading share of home market with newer products
15 September 2008
Basilea eczema drug's UK price twice estimate
15 September 2008
CV Thera initiates CVT-3619 trial
8 September 2008
Japan stock market week to Sept 1, 2008
8 September 2008
Promising mid-stage data on apixaban in ACS
8 September 2008
Daiichi Sankyo reports on Factor Xa inhibitor
8 September 2008
Revlimid effective in advanced NHL patients
8 September 2008
Ark Thera reports 68% jump in 1st half sales
8 September 2008
Skyepharma further reduces loss in first half
8 September 2008
Dong-A's ED drug approved in Russia
1 September 2008
Eisai/Helsinn's Aloxi capsules approved in USA
1 September 2008
1-in-10 US people deficient in vit B6
1 September 2008
DOR BioPharma starts orBEC NPAP for ASEAN region
1 September 2008
Ardea gets go-ahead for Ph I RDEA594 UK trial
1 September 2008
Strong Ph III data on Javelin's Dyloject
1 September 2008
JHP/SpePharm acquire rights to Dantrium
1 September 2008
ReceptorBio signs deal to develop Telik's IRAs
1 September 2008
Mundipharma's Targin fares well vs oxycodone
1 September 2008
Bayer signs deal to supply contraceptives to developing nations
1 September 2008
Pipex acquires novel RA mid-stage candidate
1 September 2008
Ziopharm granted key indibulin US and European patents
1 September 2008
Access licenses MuGard to Milestone Biosci
1 September 2008
Barr's 2nd-qtr 2008 profit rises 27%
18 August 2008
Boehringer's first-half 2008 profit drops 10%
18 August 2008
Generex receives approval to study Oral-lyn in IGT
18 August 2008
Boehringer's first-half 2008 profit drops 10%
18 August 2008
Aptivus achieves SVR in treatment-experienced children
18 August 2008
Ph III salmon calcitonin trial completes recruitment
11 August 2008
Beximco's first-half pretax profit falls 26%
11 August 2008
Evotec/Pfizer's VR1 blocker enters Ph I testing
11 August 2008
Cosmo granted key US MMX patent
11 August 2008
Bayer's 2nd-qtr 2008 net profit falls 13%
11 August 2008
S-P's boceprevir shows 74% SVR in HCV
11 August 2008
Evotec trial to be conducted by Pfizer
11 August 2008
BioAlliance adds ondansetron RapidFilm to portfolio
11 August 2008
Cephalon exceeds guidance for 2nd qtr
11 August 2008
J&J/Bayer's anticoagulant submitted for approval in USA
4 August 2008
Bayer/J&J's Xarelto gets nod from CHMP
4 August 2008
Gilead recruits for Ph III elvitegravir HIV trial
4 August 2008
Celgene pulls satraplatin MAA; weakening GPC
4 August 2008
Bayer/Onyx' Nexavar cleared for HCC in China
4 August 2008
EMEA proposes limiting use of Bayer's moxifloxacin
4 August 2008
Vitamin A can cut infant death risk in LDCs 15%
4 August 2008
GeoPharma and Cura expand Mucotrol distribution deal
28 July 2008
Sanofi terminates accord with Taiho
28 July 2008
Genzyme buys drug rights for up to $437M
28 July 2008
Teva to acquire Barr; says Israeli's Globes
21 July 2008
Teva's laquinimod enters Ph III study
21 July 2008
Rib-X starts Ph II trial of RX-3341 in cSSSI
21 July 2008
Prana publishes research on preclinical AD treatment
21 July 2008
SP MSD's rotavirus vacc winning fight?
21 July 2008
463 generics added to Japan's NHI list
14 July 2008
Mundipharma files Targin for European approval
14 July 2008
3 month delay for approval of Ligand/GSK's Promacta
14 July 2008
IDM expects L-MTP-PE EC decision in 4th qtr
14 July 2008
UPDATE: FDA panel votes in favor of outcomes over surrogate markers in diabetes drug approval
7 July 2008
JADO Tech initiates Ph II TF002 study
7 July 2008
Japan stock market week to June 30, 2008
7 July 2008
Sanofi presents new data on Rotavirus vacc
7 July 2008
Strong Ph III data for Merck & Co telcagepant
7 July 2008
GW's 1st-half turnover climbs 85.9% to L5.7M
7 July 2008
Xarelto could set new gold standard in VTE
7 July 2008
Expanded indication for Actelion's PAH drug
7 July 2008
Millennium/J&J's FDA approval for Velcade
30 June 2008
Ph IIa results for UCB's lacosamide positive but fate of drug rests on further analysis
30 June 2008
Generex Oral-lyn non-inferior to insulin analogs
30 June 2008
Novo Nordisk enters deal with Emisphere
30 June 2008
FDA lifts hold on Genta's tesetaxel trials
30 June 2008
Steifel acquires Barrier in $145M deal
30 June 2008
Bayer enters generic Yasmin deal with Barr
30 June 2008
Hybrigenics raises dosage in inecalcitol study
23 June 2008
FDA approval for GSK
23 June 2008
Abbott opens new formulation plant in HQ
23 June 2008
GSK's Tyverb gets European approval
23 June 2008
Improved anti-fungal drug targets oncology market
16 June 2008
Astex and Janssen form $500M alliance
16 June 2008
Rivaroxaban beats Lovenox: RECORD4 trial
16 June 2008
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
